Literature DB >> 16361590

Abnormalities in normal appearing tissues in early primary progressive multiple sclerosis and their relation to disability: a tissue specific magnetisation transfer study.

L Ramió-Torrentà1, J Sastre-Garriga, G T Ingle, G R Davies, V Ameen, D H Miller, A J Thompson.   

Abstract

BACKGROUND: Patients with primary progressive multiple sclerosis (PPMS) often develop severe disability despite low levels of abnormality on conventional magnetic resonance imaging (MRI). This may relate to diffuse pathological processes occurring in normal appearing brain tissue (NABT) involving both white matter (NAWM) and grey matter (NAGM). Magnetisation transfer imaging (MTI) is capable of identifying these processes and may be particularly informative when applied to patients with early PPMS. AIM: To assess the relationship between abnormalities in NABT identified by MTI and disability and other radiological data in patients with early PPMS.
METHODS: We studied 43 patients within 5 years of disease onset and 43 controls. The Expanded Disability Status Scale (EDSS) and the Multiple Sclerosis Functional Composite (MSFC) were scored. Magnetisation transfer ratios (MTR) of NABT, NAWM, and NAGM were calculated and the following MTR parameters were measured: mean, peak height, peak location, and MTR value at the 25th, 50th, and 75th percentiles. Proton density, T2, T1, and gadolinium enhancing lesion loads were also calculated.
RESULTS: Differences were found between patients and controls in mean, peak height, and peak location of NAWM and NAGM (p < or = 0.001). Weak to moderate correlations were found between MTR parameters and disability in both NAWM and NAGM. Strong correlations between MTR parameters and lesion loads were found, particularly in NAWM.
CONCLUSION: MTR abnormalities are seen in NAWM and NAGM in early PPMS and both are associated with disability. NAWM MTR abnormalities are more closely related to conventional MRI measures than those seen in NAGM.

Entities:  

Mesh:

Year:  2006        PMID: 16361590      PMCID: PMC2117405          DOI: 10.1136/jnnp.2004.052316

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  30 in total

Review 1.  Primary progressive multiple sclerosis.

Authors:  A J Thompson; C H Polman; D H Miller; W I McDonald; B Brochet; X Filippi M Montalban; J De Sá
Journal:  Brain       Date:  1997-06       Impact factor: 13.501

2.  An interleaved sequence for accurate and reproducible clinical measurement of magnetization transfer ratio.

Authors:  G J Barker; P S Tofts; A Gass
Journal:  Magn Reson Imaging       Date:  1996       Impact factor: 2.546

3.  Magnetization transfer study of HIV encephalitis and progressive multifocal leukoencephalopathy. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine.

Authors:  V Dousset; J P Armand; D Lacoste; S Mièze; L Letenneur; J F Dartigues; J M Caill
Journal:  AJNR Am J Neuroradiol       Date:  1997-05       Impact factor: 3.825

4.  Axonal transection in the lesions of multiple sclerosis.

Authors:  B D Trapp; J Peterson; R M Ransohoff; R Rudick; S Mörk; L Bö
Journal:  N Engl J Med       Date:  1998-01-29       Impact factor: 91.245

5.  Lysolecithin-induced demyelination in primates: preliminary in vivo study with MR and magnetization transfer.

Authors:  V Dousset; B Brochet; A Vital; C Gross; A Benazzouz; A Boullerne; A M Bidabe; A M Gin; J M Caille
Journal:  AJNR Am J Neuroradiol       Date:  1995-02       Impact factor: 3.825

6.  Measure of magnetization transfer in multiple sclerosis demyelinating plaques, white matter ischemic lesions, and edema.

Authors:  R C Mehta; G B Pike; D R Enzmann
Journal:  AJNR Am J Neuroradiol       Date:  1996 Jun-Jul       Impact factor: 3.825

7.  Diagnostic criteria for primary progressive multiple sclerosis: a position paper.

Authors:  A J Thompson; X Montalban; F Barkhof; B Brochet; M Filippi; D H Miller; C H Polman; V L Stevenson; W I McDonald
Journal:  Ann Neurol       Date:  2000-06       Impact factor: 10.422

8.  Magnetisation transfer ratio histogram analysis of primary progressive and other multiple sclerosis subgroups.

Authors:  J Dehmeshki; N C Silver; S M Leary; P S Tofts; A J Thompson; D H Miller
Journal:  J Neurol Sci       Date:  2001-03-15       Impact factor: 3.181

9.  Magnetisation transfer of normal appearing white matter in primary progressive multiple sclerosis.

Authors:  S M Leary; N C Silver; V L Stevenson; G J Barker; D H Miller; A J Thompson
Journal:  Mult Scler       Date:  1999-10       Impact factor: 6.312

10.  Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability.

Authors:  J H van Waesberghe; W Kamphorst; C J De Groot; M A van Walderveen; J A Castelijns; R Ravid; G J Lycklama à Nijeholt; P van der Valk; C H Polman; A J Thompson; F Barkhof
Journal:  Ann Neurol       Date:  1999-11       Impact factor: 10.422

View more
  23 in total

1.  White and gray matter damage in primary progressive MS: The chicken or the egg?

Authors:  Benedetta Bodini; Declan Chard; Daniel R Altmann; Daniel Tozer; David H Miller; Alan J Thompson; Claudia Wheeler-Kingshott; Olga Ciccarelli
Journal:  Neurology       Date:  2015-12-16       Impact factor: 9.910

2.  Exploring the relationship between white matter and gray matter damage in early primary progressive multiple sclerosis: an in vivo study with TBSS and VBM.

Authors:  Benedetta Bodini; Zhaleh Khaleeli; Mara Cercignani; David H Miller; Alan J Thompson; Olga Ciccarelli
Journal:  Hum Brain Mapp       Date:  2009-09       Impact factor: 5.038

Review 3.  MRI in multiple sclerosis: what's inside the toolbox?

Authors:  Mohit Neema; James Stankiewicz; Ashish Arora; Zachary D Guss; Rohit Bakshi
Journal:  Neurotherapeutics       Date:  2007-10       Impact factor: 7.620

Review 4.  The role of advanced magnetic resonance imaging techniques in primary progressive MS.

Authors:  Maria A Rocca; Martina Absinta; Massimo Filippi
Journal:  J Neurol       Date:  2011-08-04       Impact factor: 4.849

Review 5.  Axo-glial antigens as targets in multiple sclerosis: implications for axonal and grey matter injury.

Authors:  Tobias Derfuss; Chris Linington; Reinhard Hohlfeld; Edgar Meinl
Journal:  J Mol Med (Berl)       Date:  2010-05-06       Impact factor: 4.599

6.  A longitudinal study of MRI-detected atrophy in secondary progressive multiple sclerosis.

Authors:  J Furby; T Hayton; D Altmann; R Brenner; J Chataway; K J Smith; D H Miller; R Kapoor
Journal:  J Neurol       Date:  2010-05-01       Impact factor: 4.849

7.  Evidence for early neurodegeneration in the cervical cord of patients with primary progressive multiple sclerosis.

Authors:  Khaled Abdel-Aziz; Torben Schneider; Bhavana S Solanky; Marios C Yiannakas; Dan R Altmann; Claudia A M Wheeler-Kingshott; Amy L Peters; Brian L Day; Alan J Thompson; Olga Ciccarelli
Journal:  Brain       Date:  2015-04-10       Impact factor: 13.501

8.  Grey matter magnetization transfer ratio independently correlates with neurological deficit in secondary progressive multiple sclerosis.

Authors:  T Hayton; J Furby; K J Smith; D R Altmann; R Brenner; J Chataway; R A C Hughes; K Hunter; D J Tozer; D H Miller; R Kapoor
Journal:  J Neurol       Date:  2009-03-06       Impact factor: 4.849

Review 9.  Magnetization transfer magnetic resonance imaging of the brain, spinal cord, and optic nerve.

Authors:  Massimo Filippi; Maria A Rocca
Journal:  Neurotherapeutics       Date:  2007-07       Impact factor: 7.620

Review 10.  Neuropathogenesis of Theiler's murine encephalomyelitis virus infection, an animal model for multiple sclerosis.

Authors:  Ikuo Tsunoda; Robert S Fujinami
Journal:  J Neuroimmune Pharmacol       Date:  2009-11-06       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.